CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Regulation FD disclosure
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market sale CBO & COO sold 100,000 shares at an average $128.05 ($12,805,240)
- 4 Open-market sale Director sold 30,374 shares at an average $132.37 ($4,020,667)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,352 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 5,526 shares (to pay taxes)
- 4 Shares withheld for taxes CBO & COO gave up 2,141 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 1,353 shares (to pay taxes)
- 4 Shares withheld for taxes Executive VP, Head of R&D gave up 2,141 shares (to pay taxes)
- 4/A Option exercise CBO & COO acquired 16,334 shares (option exercise)
- 4 Shares withheld for taxes Executive VP, Head of R&D gave up 1,585 shares (to pay taxes)
- 4 Other disposition Director disposed of 338,165 shares (other)
- 4 Shares withheld for taxes Chief Executive Officer gave up 798 shares (to pay taxes)
- 4 Open-market sale Director sold 171,003 shares at an average $149.11 ($25,497,840)
- SC 13G/A Stake Amended Statement of Ownership
Page 21 of 45 · 883 filings